MetLife Investment Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21,757
Closed -$7.08M 2943
2024
Q1
$7.08M Sell
21,757
-528
-2% -$130K 0.05% 334
2023
Q4
$4.25M Sell
22,285
-276
-1% -$52.2K 0.03% 566
2023
Q3
$4.49M Sell
22,561
-892
-4% -$211K 0.04% 468
2023
Q2
$6.69M Sell
23,453
-16,654
-42% -$4.62M 0.05% 326
2023
Q1
$8.7M Sell
40,107
-594
-1% -$116K 0.06% 244
2022
Q4
$8.37M Sell
40,701
-557
-1% -$141K 0.06% 245
2022
Q3
$11.5M Buy
41,258
+250
+0.6% +$63.6K 0.1% 168
2022
Q2
$7.84M Buy
41,008
+22,944
+127% +$4.05M 0.06% 252
2022
Q1
$3.75M Buy
18,064
+6,403
+55% +$1.06M 0.02% 706
2021
Q4
$2.08M Hold
11,661
0.02% 857
2021
Q3
$2.4M Sell
11,661
-355
-3% -$69.7K 0.02% 775
2021
Q2
$2.28M Buy
12,016
+950
+9% +$155K 0.02% 825
2021
Q1
$1.44M Sell
11,066
-1,018
-8% -$122K 0.01% 976
2020
Q4
$1.25M Hold
12,084
0.01% 1030
2020
Q3
$916K Buy
12,084
+749
+7% +$42.5K 0.01% 1066
2020
Q2
$537K Hold
11,335
0.01% 1338
2020
Q1
$376K Hold
11,335
0.01% 1365
2019
Q4
$498K Buy
11,335
+7,382
+187% +$273K 0.01% 1466
2019
Q3
$118K Hold
3,953
﹤0.01% 2238
2019
Q2
$226K Buy
+3,953
New +$192K ﹤0.01% 1960

Other funds holding SWAV

MetLife Investment Management's SWAV Position: Q2 2024 in Review

MetLife Investment Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 21,757 shares — an estimated $7.08M sold.

MetLife Investment Management first reported a position in SWAV in Q2 2019 and held it in 20 quarters. The position peaked at $11.5M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • MetLife Investment Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • MetLife Investment Management sold 21,757 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $7.08M.
  • MetLife Investment Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 20 quarters.
  • MetLife Investment Management's Shockwave Medical, Inc. Common Stock position peaked at $11.5M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.